Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    An NIH banner announces a transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) across federal agency content and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:42:17.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T01:28:30.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T01:56:57.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added. A number of study document attachments were removed from the Study Documents section, including the Informed Consent Form (2019-12-04) and the Study Protocol/Statistical Analysis Plan PDFs.
    Difference
    18%
    Check dated 2026-09-20T00:41:00.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, updating from v3.6.5. This reflects a software or interface update to the study page rather than a modification to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T19:44:22.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a minor platform update to the page.
    Difference
    0.1%
    Check dated 2026-08-08T18:19:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.